Rifampcin-induced Thrombocytopaenia Purpura.

We report the case of a 28-year-old resident doctor with no past history of having taken rifampicin, who presented with thrombocytoapaenic purpura occurring after the initiation of anti-tuberculosis therapy (isoniazid, rifampicin, pyrazinamide and ethambutol) for tubercular lymphadenopathy. PMID: 30152654 [PubMed - in process]
Source: Indian Journal of Chest Diseases and Allied Sciences - Category: Respiratory Medicine Tags: Indian J Chest Dis Allied Sci Source Type: research